Research and Breakthroughs

CHLA is one of just six centers in the country participating in a study that aims to identify key EEG biomarkers in Rett syndrome.

A CHLA study finds a striking disparity in families’ use—and knowledge of—AAC devices for children with autism.

The machine learning model quantifies a child’s individual risk of developing permanent hearing loss from the chemotherapy drug cisplatin.

A CHLA heart surgeon presented the xenotransplant results in a plenary session at the International Society for Heart and Lung Transplantation meeting.

The study analyzed data from children aged birth to 5 years referred to CHLA for Medicaid-funded mental health services.

The study aims to find out if therapeutic cooling should be the standard of care for newborns with mild hypoxic ischemic encephalopathy.

Jonathan Santana, DO, and Tishya Wren, PhD, led a team of CHLA researchers who determined that children take longer to recover from non-sports-related concussions, and that age and gender also affect

Novel MRI techniques can provide new treatment insights for single-ventricle heart disease.

Under a five-year, $1.65 million National Institutes of Health grant, CHLA researchers aim to mimic the transformation of a healthy cell into neuroblastoma.

CHLA study shows diagnostic procedure to extract aqueous humor in liquid biopsy is safe and well tolerated in children with retinoblastoma